Chemical Structure (Steglujan 01)
Steglujan Tablet, Film Coated
Product Images NDC 0006-5367
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Steglujan (NDC 0006-5367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Steglujan 02)
Figure 1 (Steglujan 03)
Figure 2 (Steglujan 04)
Figure 3 (Steglujan 05)
Principal Display Panel (5 mg/100 mg Tablet Bottle Label)
This is a description of a medication with NDC code 0006-5367-03. It is a pack of 30 tablets of Steglujan, a drug containing 5mg/100mg of sitagliptin and ertugliflozin. It also includes a medication guide. There is space reserved for a 2D serialization barcode that contains information about the product's serial number, expiry, and lot number.*
Principal Display Panel (15 mg/100 mg Tablet Bottle Label)
Steglujan is a medication that comes in tablet form and contains ertugliflozin and sitagliptin. The GTIN code for this medication is 0030065368030. Each tablet consists of 19.43mg of ertugliflozin and 128.5mg of sitagliptin phosphate. It is recommended to give a Medication Guide along with the tablets. The usual dosage is not available. Store Steglujan at 20°C25° and protect from moisture.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
